ARTICLE | Company News
CBio, Novo Nordisk deal
January 2, 2012 8:00 AM UTC
CBio said Novo Nordisk will not exercise its option under a May 2008 deal to negotiate an exclusive license to CBio's autoimmune product XToll ( Cpn10). The recombinant heat shock protein 10 (hsp10)...